Willem Kuyken

Willem Kuyken


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Clinical Psychology Review
Verified
Journal Article
Open access
CSClara Strauss
Clara Strauss
BTBillie Lever Taylor
Billie Lever Taylor
JGJenny Gu
Jenny Gu
WKWillem Kuyken
Willem Kuyken
RBRuth Baer
Ruth Baer
KCKate Cavanagh
Kate Cavanagh
The importance of compassion is widely recognized and it is receiving increasing research attention. Yet, there is lack of consensus on definition and a paucity of psychometrically robust measures of this construct. Without an agreed definition and adequate measures, we cannot study compassion, measure compassion or evaluate whether interventions designed to enhance compassion are effective. In response, this paper proposes a definition of compassion and offers a systematic review of self- and observer-rated measures. Following consolidation of existing definitions, we propose that compassion consists of five elements: recognizing suffering, understanding the universality of human suffering, feeling for the person suffering, tolerating uncomfortable feelings, and motivation to act/acting to alleviate suffering. Three databases were searched (Web of Science, PsycInfo, and Medline) and nine measures included and rated for quality. Quality ratings ranged from 2 to 7 out of 14 with low ratings due to poor internal consistency for subscales, insufficient evidence for factor structure and/or failure to examine floor/ceiling effects, test-retest reliability, and discriminant validity. We call our five-element definition, and if supported, the development of a measure of compassion based on this operational definition, and which demonstrates adequate psychometric properties.

29 December 2016 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
RCR. S. Crane
R. S. Crane
JBJ. Brewer
J. Brewer
CFC. Feldman
C. Feldman
JKJ. Kabat-Zinn
J. Kabat-Zinn
SSS. Santorelli
S. Santorelli
WKWillem Kuyken
Willem Kuyken
There has been an explosion of interest in mindfulness-based programs (MBPs) such as Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy. This is demonstrated in increased research, implementation of MBPs in healthcare, educational, criminal justice and workplace settings, and in mainstream interest. For the sustainable development of the field there is a need to articulate a definition of what an MBP is and what it is not. This paper provides a framework to define the essential characteristics of the family of MBPs originating from the parent program MBSR, and the processes which inform adaptations of MBPs for different populations or contexts. The framework addresses the essential characteristics of the program and of teacher. MBPs: are informed by theories and practices that draw from a confluence of contemplative traditions, science, and the major disciplines of medicine, psychology and education; underpinned by a model of human experience which addresses the causes of human distress and the pathways to relieving it; develop a new relationship with experience characterized by present moment focus, decentering and an approach orientation; catalyze the development of qualities such as joy, compassion, wisdom, equanimity and greater attentional, emotional and behavioral self-regulation, and engage participants in a sustained intensive training in mindfulness meditation practice, in an experiential inquiry-based learning process and in exercises to develop understanding. The paper's aim is to support clarity, which will in turn support the systematic development of MBP research, and the integrity of the field during the process of implementation in the mainstream.

1 June 2016 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
WKWillem Kuyken
Willem Kuyken
FWFiona C. Warren
Fiona C. Warren
RTRod S. Taylor
Rod S. Taylor
BWBen Whalley
Ben Whalley
CCCatherine Crane
Catherine Crane
TDTim Dalgleish
Tim Dalgleish
Although progress has been made in the treatment of many psychiatric conditions, recurrent depression continues to cause significant disability and remains a high cost to society.1,2 Interventions that prevent depressive relapse among people at high risk of recurrent episodes have significant potential to reduce the disease’s burden.3 Mindfulness-based cognitive therapy (MBCT), one such intervention, teaches psychological skills that target cognitive mechanisms implicated in depressive relapse to people with a history of depression4 by combining systematic mindfulness training with elements from cognitive therapy. A systematic review and meta-analysis5 of 6 randomized clinical trials (N = 593 patients) suggested that MBCT was associated with a significant reduction in the rates of depressive relapse compared with usual care or placebo, corresponding to a 34% relative risk reduction (risk ratio [RR], 0.66; 95% CI, 0.53-0.82).

1 November 2010 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
WKWillem Kuyken
Willem Kuyken
EWEdward Watkins
Edward Watkins
EHEmily Holden
Emily Holden
KWKat White
Kat White
RTRod S. Taylor
Rod S. Taylor
TDTim Dalgleish
Tim Dalgleish

1 January 2008 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
WKWillem Kuyken
Willem Kuyken
SBSarah Byford
Sarah Byford
RTRod S. Taylor
Rod S. Taylor
EWEdward Watkins
Edward Watkins
EHEmily Holden
Emily Holden
JTJohn D. Teasdale
John D. Teasdale
For people at risk of depressive relapse, mindfulness-based cognitive therapy (MBCT) has an additive benefit to usual care (H. F. Coelho, P. H. Canter, & E. Ernst, 2007). This study asked if, among patients with recurrent depression who are treated with antidepressant medication (ADM), MBCT is comparable to treatment with maintenance ADM (m-ADM) in (a) depressive relapse prevention, (b) key secondary outcomes, and (c) cost effectiveness. The study design was a parallel 2-group randomized controlled trial comparing those on m-ADM (N = 62) with those receiving MBCT plus support to taper/discontinue antidepressants (N = 61). Relapse/recurrence rates over 15-month follow-ups in MBCT were 47%, compared with 60% in the m-ADM group (hazard ratio = 0.63; 95% confidence interval: 0.39 to 1.04). MBCT was more effective than m-ADM in reducing residual depressive symptoms and psychiatric comorbidity and in improving quality of life in the physical and psychological domains. There was no difference in average annual cost between the 2 groups. Rates of ADM usage in the MBCT group was significantly reduced, and 46 patients (75%) completely discontinued their ADM. For patients treated with ADM, MBCT may provide an alternative approach for relapse prevention.

1 August 2016 in The Lancet
Verified
Journal Article
Open access
DRDavid A Richards
David A Richards
DEDavid Ekers
David Ekers
DMDean McMillan
Dean McMillan
RTRod S Taylor
Rod S Taylor
SBSarah Byford
Sarah Byford
KFKatie Finning
Katie Finning
Depression is a common, debilitating, and costly disorder. Many patients request psychological therapy, but the best-evidenced therapy-cognitive behavioural therapy (CBT)-is complex and costly. A simpler therapy-behavioural activation (BA)-might be as effective and cheaper than is CBT. We aimed to establish the clinical efficacy and cost-effectiveness of BA compared with CBT for adults with depression. In this randomised, controlled, non-inferiority trial, we recruited adults aged 18 years or older meeting Diagnostic and Statistical Manual of Mental Disorders IV criteria for major depressive disorder from primary care and psychological therapy services in Devon, Durham, and Leeds (UK). We excluded people who were receiving psychological therapy, were alcohol or drug dependent, were acutely suicidal or had attempted suicide in the previous 2 months, or were cognitively impaired, or who had bipolar disorder or psychosis or psychotic symptoms. We randomly assigned participants (1:1) remotely using computer-generated allocation (minimisation used; stratified by depression severity [Patient Health Questionnaire 9 (PHQ-9) score of <19 vs ≥19], antidepressant use, and recruitment site) to BA from junior mental health workers or CBT from psychological therapists. Randomisation done at the Peninsula Clinical Trials Unit was concealed from investigators. Treatment was given open label, but outcome assessors were masked. The primary outcome was depression symptoms according to the PHQ-9 at 12 months. We analysed all those who were randomly allocated and had complete data (modified intention to treat [mITT]) and also all those who were randomly allocated, had complete data, and received at least eight treatment sessions (per protocol [PP]). We analysed safety in the mITT population. The non-inferiority margin was 1·9 PHQ-9 points. This trial is registered with the ISCRTN registry, number ISRCTN27473954. Between Sept 26, 2012, and April 3, 2014, we randomly allocated 221 (50%) participants to BA and 219 (50%) to CBT. 175 (79%) participants were assessable for the primary outcome in the mITT population in the BA group compared with 189 (86%) in the CBT group, whereas 135 (61%) were assessable in the PP population in the BA group compared with 151 (69%) in the CBT group. BA was non-inferior to CBT (mITT: CBT 8·4 PHQ-9 points [SD 7·5], BA 8·4 PHQ-9 points [7·0], mean difference 0·1 PHQ-9 points [95% CI -1·3 to 1·5], p=0·89; PP: CBT 7·9 PHQ-9 points [7·3]; BA 7·8 [6·5], mean difference 0·0 PHQ-9 points [-1·5 to 1·6], p=0·99). Two (1%) non-trial-related deaths (one [1%] multidrug toxicity in the BA group and one [1%] cancer in the CBT group) and 15 depression-related, but not treatment-related, serious adverse events (three in the BA group and 12 in the CBT group) occurred in three [2%] participants in the BA group (two [1%] patients who overdosed and one [1%] who self-harmed) and eight (4%) participants in the CBT group (seven [4%] who overdosed and one [1%] who self-harmed). We found that BA, a simpler psychological treatment than CBT, can be delivered by junior mental health workers with less intensive and costly training, with no lesser effect than CBT. Effective psychological therapy for depression can be delivered without the need for costly and highly trained professionals. National Institute for Health Research.